Date of announcement 2021/11/18
Time of announcement 19:56:31
Date of events 2021/11/18
To which item it meets paragraph 20
1.Name and nature of the underlying assets (if preferred shares, the terms and conditions of issuance shall also be indicated, e.g., dividend yield, etc.): Subordinated Convertible Note (“CN”) issued by CDIB Medtech Investment Partners Limited (“Medtech Investment Partners”) 2.Date of occurrence of the event:2021/11/18 3.Amount, unit price, and total monetary amount of the transaction: Not Applicable, Not Applicable, up to US$20M 4.Trading counterparty and its relationship with the Company (if the trading counterparty is a natural person and furthermore is not a related party of the Company, the name of the trading counterparty is not required to be disclosed): Trading Counterparty: Medtech Investment Partners; Its relationship with the Company: Related party as defined in the Regulations Governing the Preparation of Financial Reports by Securities Issuers to the Company while the Company’s acquisition of CN 5.Where the trading counterparty is a related party, announcement shall also be made of the reason for choosing the related party as trading counterparty and the identity of the previous owner, its relationship with the Company and the trading counterparty, and the previous date and monetary amount of transfer: Reason for choosing: For the need of investment business development; No previous transfer. 6.Where an owner of the underlying assets within the past five years has been a related party of the Company, the announcement shall also include the date and price of acquisition and disposal by the related party, and its relationship with the Company at the time of the transaction: Not Applicable 7.Matters related to the current disposal of creditors' rights (including types of collaterals of the disposed creditor’s rights; if creditor's rights over a related party, announcement shall be made of the name of the related party and the book amount of the creditor's rights, currently being disposed of, over such related party):Not Applicable 8.Profit or loss from the disposal (not applicable in cases of acquisition of securities) (those with deferral should provide a table explaining recognition):Not Applicable 9.Terms of delivery or payment (including payment period and monetary amount), restrictive covenants in the contract, and other important terms and conditions: Per contract 10.The manner of deciding on this transaction (such as invitation to tender, price comparison, or price negotiation), the reference basis for the decision on price, and the decision-making unit: Mutual agreement, Board of directors 11.Net worth per share of the Company's underlying securities acquired or disposed of:Not applicable 12.Cumulative no.of shares held (including the current transaction), their monetary amount, shareholding percentage, and status of any restriction of rights (e.g., pledges), as of the present moment: Not Applicable, Up to US$20M, Not Applicable, Nil 13.Current ratio of securities investment (including the current trade, as listed in article 3 of Regulations Governing the Acquisition and Disposal of Assets by Public Companies) to the total assets and equity attributable to owners of the parent as shown in the most recent financial statement and working capital as shown in the most recent financial statement as of the present: To the total assets:1.09%; To the equity attributable to owners of the parent:1.34%; Working Capital: Not applicable 14.Broker and broker's fee:Nil 15.Concrete purpose or use of the acquisition or disposal: For the need of investment business development 16.Any dissenting opinions of directors to the present transaction:Nil 17.Whether the counterparty of the current transaction is a related party:Yes 18.Date of the board of directors resolution:2021/11/18 19.Date of ratification by supervisors or approval by the Audit Committee:NA 20.Whether the CPA issued an unreasonable opinion regarding the current transaction:Nil 21.Name of the CPA firm:YANGTZE CPAS & CO. 22.Name of the CPA:Hu, Hsiang-Ning 23.Practice certificate number of the CPA:191 24.Whether the transaction involved in change of business model:No 25.Details on change of business model:Not Applicable 26.Details on transactions with the counterparty for the past year and the expected coming year:Not Applicable 27.Source of funds:The Company’s own capital 28.Any other matters that need to be specified: (1) USD 1 = NTD 27.84 (as of 2021/11/11) (2) “GM” is short for “CDIB Global Markets Limited”.